Tomohiro Miwata
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 5
- Gastroesophageal reflux and treatments 2
-
- Gastric Cancer Management and Outcomes 10
- Metastasis and carcinoma case studies 7
-
- Esophageal and GI Pathology 3
- Esophageal Cancer Research and Treatment 3
-
- Colorectal Cancer Screening and Detection 2
-
- Genetic factors in colorectal cancer 2
Tomohiro Miwata
17 papers receiving 345 citations
Peers
Comparison fields: 5 of 27
- Gastroenterology 80
- Pulmonary and Respiratory Medicine 280
- Surgery 261
- Oncology 56
- Pathology and Forensic Medicine 21
Countries citing papers authored by Tomohiro Miwata
This map shows the geographic impact of Tomohiro Miwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Miwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Miwata more than expected).
Fields of papers citing papers by Tomohiro Miwata
This network shows the impact of papers produced by Tomohiro Miwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Miwata. The network helps show where Tomohiro Miwata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomohiro Miwata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 18 | |
| 2 | 2022 | 8 | |
| 3 | 2019 | 22 | |
| 4 | [A Case of Resected Esophageal Endocrine Cell Carcinoma That Responded to Combination Therapy Comprising Irinotecan and Cisplatin]. | 2018 | 0 |
| 5 | 2017 | 44 | |
| 6 | 2017 | 5 | |
| 7 | 2016 | 14 | |
| 8 | 2016 | 28 | |
| 9 | 2016 | 22 | |
| 10 | 2015 | 64 | |
| 11 | 2015 | 32 | |
| 12 | 2014 | 44 | |
| 13 | 2014 | 8 | |
| 14 | 2013 | 11 | |
| 15 | 2010 | 25 | |
| 16 | [A case of effective chemotherapy using S-1 and CPT-11 following chemoradiotherapy with UFT and Leucovorin for unresectable advanced sigmoid colon cancer]. | 2010 | 3 |
| 17 | [A case of effective chemoradiotherapy using S-1 and CDDP for left inguinal lymph node metastasis of anal canal carcinoma]. | 2009 | 1 |
| 18 | [Yakon tea induced hepatitis in a patient with alcoholic liver cirrhosis]. | 2009 | 1 |
About Tomohiro Miwata
Tomohiro Miwata is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Surgery, having authored 18 papers that have together received 350 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (10 papers), Metastasis and carcinoma case studies (7 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Esophageal and GI Pathology (3 papers), Esophageal Cancer Research and Treatment (3 papers), Gastroesophageal reflux and treatments (2 papers), Genetic factors in colorectal cancer (2 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Gastroenterology (80 citations), Pulmonary and Respiratory Medicine (280 citations) and Surgery (261 citations). Tomohiro Miwata has collaborated with scholars based in Japan, Vietnam and Switzerland. Frequent co-authors include Kazuaki Chayama, Shinji Tanaka, Toru Hiyama, Yoji Sanomura, Yuji Urabe, Shiro Oka, Yoshikazu Yoshifuku, Koji Arihiro, Shiro Oka and Hideharu Okanobu. Their work appears in journals such as Gastrointestinal Endoscopy, Surgical Endoscopy and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.